3 High-Growth Stocks Down 25% to Buy Before the 2026 Tech Rebound

Three large-cap tech names—Microsoft, Broadcom and Meta—are each down roughly 25%+, with Microsoft off >30% from its all-time high, presenting the author as a buy opportunity. Meta plans $115–$135 billion of capex this year, reported Q4 revenue +24% YoY and trades at ~19x forward earnings. Broadcom's AI semiconductor division generated $8.4B in Q1 FY2026 (annualized ~$34B) and CEO Hock Tan forecasts $100B in custom AI chip revenue by end-2027. The piece frames AI leadership, strong execution and depressed valuations as the drivers for a bullish investment case.

Analysis

Broadcom is the asymmetric trade here because hyperscalers’ willingness to trade generality for price/performance creates a winner-take-most design-vendor with multi-year locked-in revenue and higher ASP wafer pull for its foundry partners. That dynamics favors companies that can co-design silicon+firmware+system integration (Broadcom-style) and hurts small GPU specialists that rely on broad, general-purpose demand; watch TSMC slot allocation and lead times as the single biggest operational constraint to realizing the revenue ramp.

Microsoft’s enterprise AI moat is less about a single product and more about friction in moving mission-critical workflows onto an Azure/OpenAI fabric; that stickiness creates high-margin annuity upside but also sets up a two-way bet where Microsoft could subsidize ingress (cloud credits, model access) and compress near-term margins to accelerate share — a 12–24 month payoff timeline for visible earnings inflection. Meta’s aggressive capex is a real option: if product-level improvements lift CPMs and ARPU, payback is fast, but that path is fully contingent on advertising demand stability and measurable improvements in recommendation efficiency.

Key catalysts that will re-rate these names are: confirmed hyperscaler design wins (public disclosures or supply-chain bookings) for custom chips, sequential cloud AI ARR growth and gross margin stabilization at Microsoft, and ad monetization metrics at Meta. Tail risks include an advertising recession, a broad enterprise pause on AI spend, regulatory interventions around large-scale model deployments, or wafer-capacity bottlenecks that delay shipments.

The market appears to have over-discounted execution optionality and under-discounted lock-in economics: if even one hyperscaler publicly commits to a Broadcom design and Microsoft shows non-linear ARPU from AI features, re-rates could be sharp and asymmetric. That said, the path is bumpy — earnings windows and supply announcements will drive most of the next 6–12 months’ move.

Key Decisions for Investors

• Initiate a 12–18 month bullish call spread on AVGO (buy-dated call / sell higher strike) sized to 1.0–1.5% NAV: objective is to capture a 30–50% upside from validated hyperscaler design wins; max loss = premium (~100% of allocation to the spread).
• Pair trade (6–12 months): long MSFT / short META, equal dollar weights at 1–2% NAV each leg. Rationale: hedge market beta while expressing asymmetry of enterprise AI monetization vs cyclical ad exposure; take profits if spread tightens >20% or cut if both names move >15% against on macro news.
• Tactical event trade (0–3 months): buy near-term (1–3 month) AVGO earnings-call call options sized small (0.5% NAV) to play a potential guidance upside from design-win disclosures; limit exposure to option premium only and use time decay as stop-loss.
• If access to OTC: negotiate a structured financing with Broadcom exposure (principal-protected note or buffered note) to capture multi-year upside while limiting downside to a pre-defined buffer — target 3–5% annualized cost for a 20–40% upside cap over 24 months.
• Risk controls: total tech-AI directional exposure to these ideas capped at 5% NAV; set hard stop-losses at 12–18% per position, and reassess after quarterly earnings or any public hyperscaler design confirmation.